Journal of Ophthalmology & Clinical Research(JOCR)
ISSN: 2573-9573 | DOI: 10.33140/JOCR
Impact Factor: 1.396
Researchers and authors can directly submit their manuscript online through this link Online Manuscript Submission.
Treatment of Subretinal Neovascular Membranes in a Patient with Membranoproliferative Glomerulonephritis Type II: A Longitudinal Case Report
Abstract
Max D Schlesinger and Samer E Farah
A 38-year-old woman with membranoproliferative glomerulonephritis type II (MPGN II), previously treated successfully for choroidal neovascular membrane (CNV) in the left eye with injections of anti-vascular endothelial growth factor (VEGF) therapy, subsequently developed blurry vision due to new CNV in her right eye. She was treated with a total of 6 intravitreal injections of ranibizumab, with improvement in acuity and imaging findings. At her most recent follow up visit prior to the writing of this paper, nearly 10 years after her initial presentation with left eye CNV and 7.5 years after developing right eye CNV, she remains recurrence-free.